Today, more than 300 clinical trials¹ are ongoing worldwide to uncover the potential of MSCs. Thus far, encouraging results have been published; stem cell treatments have been proven safe and capable of repairing damage caused by stroke and heart disease. MSCs have also been used in combination with HSCs as a dual therapy to promote faster engraftment of HSCs and to reduce immune system complications².

EpSC Clinical Trials – Global Institutions

Diseases	Names of Universities or Research Institutions
Skin Wound	Singapore General Hospital Burn Centre
Ocular surface disorders	Singapore Eye Research Institute Kyoto Prefectural University of Medicine, Japan
Persistent epithelial defect	National Eye Institute, Hanoi, Vietnam

MSC Clinical Trials – Global Institutions

Diseases	Names of Universities or Research Institutions
Stroke	University Hospital, Grenoble, France
Spinal Cord Injury	Chinese University of Hong Kong Cairo University, Egypt
Multiple Sclerosis	Spain-Carlos Health Institute University of Cambridge, United Kingdom Cleveland Clinic, United States
Amyotrophic Lateral Sclerosis	Hadassah Medical Organization, Israel
Parkinson‘s Disease	Jaslok Hospital and Research Centre, India
Multiple System Atrophy	Yonsei University, South Korea
Liver Disease	Cytori Therapeutics, United States
Diabetic Foot Ulcer	Third Military Medical University, China Washington DC Veterans Medical Centre, United States Ruhr-University Bochum, Germany
Diabetes	Fuzhou General Hospital, China Uppsala University, Sweden

 

Worldwide researches on diseases treated with MSCs by various universities or institutions:

Diseases	Name of universities or research Institions
Stroke	University Hospital, Grenobe, France
Spinal Cord Injury	Cairo University, Egypt Chinese University of Hong Kong
Multiple Sclerosis	Spain-Carlos Health Institute University of Cambridge, U.K. Cleveland Clinic, U.S.
Amylotrophic Lateral Sclerosis	Hadassah Medical Organization, Israel
Parkinson's Disease	Jaslok Hospital and Research Centre, India
Multiple System Atrophy	Yonsei University, South Korea
Liver Disease	Cytori Therapeutics, U.S.
Diabetic Foot Ulcer	Third Military Medical University, China Washington DC Veterans Medical Centre, U.S. Ruhr-University Bochum, Germany
Diabetes	FUzhou General Hospital, China Uppsala University, Sweden

 

 

Sources:

1. ClinicalTrials.gov. Accessed in October 2013.
2. Battiwalla M, Hematti P. 2010. Cytotherapy. 1 January 2010.